fbpx

The retina deciphered

 

American researchers have published the most thorough description to date of gene expression in the human retina. And it comes with a few surprises.

 

The investigators at Massachusetts Eye and Ear and Harvard Medical School used a technique called RNA sequencing to demonstrate that the majority of the 20,000 genes in the human body are expressed in the retina. This was no real surprise to the scientific community, because the retina is a complex tissue with 60 types of cells.

 

The investigators were quite excited, however, to discover nearly 30,000 new exons and more than 100 potential new genes. Exons are the portions of the genome that are used to encode proteins or other genetic elements. Several thousand of the newly discovered exons appear to be used specifically in the retina.

 

These discoveries will help researchers to better understand how the retina works as well as how it is affected by various diseases, such as inherited degenerations, which result from genetic mutations or errors. While more than 200 genes related to retinal degenerative disease have been identified, scientists have yet to find the cause of disease for up to half of the patients with such disorders. The newly identified exons in the retina may change all that.

Sources:

http://www.sciencedaily.com/releases/2013/07/130718130458.htm  

 

http://www.biomedcentral.com/1471-2164/14/486/abstract 

Featured Posts

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

Learn More
MIDO Square

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Read more
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

Read more
CooperCompanies

CooperCompanies Recognized as a Best Workplace for Innovators

Leading global medical device company recognized for culture that drives innovation for customers and patients.

Read more
Nikon Optical Canada logo

Nikon Optical Unveils “Vision You Can Feel” Campaign in Canada

Nikon Optical Canada announces its launch of the 2024 brand campaign, Vision You Can Feel.

Read more

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

Learn More
MIDO Square

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Read More
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

Read More
CooperCompanies

CooperCompanies Recognized as a Best Workplace for Innovators

Leading global medical device company recognized for culture that drives innovation for customers and patients.

Read More
Nikon Optical Canada logo

Nikon Optical Unveils “Vision You Can Feel” Campaign in Canada

Nikon Optical Canada announces its launch of the 2024 brand campaign, Vision You Can Feel.

Read More

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

Learn More
MIDO Square

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Read more
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

Read more
CooperCompanies

CooperCompanies Recognized as a Best Workplace for Innovators

Leading global medical device company recognized for culture that drives innovation for customers and patients.

Read more
Nikon Optical Canada logo

Nikon Optical Unveils “Vision You Can Feel” Campaign in Canada

Nikon Optical Canada announces its launch of the 2024 brand campaign, Vision You Can Feel.

Read more

Canadian Optical Supply Announces Passing of Co-founder Judith Hochstadter

Judith Hochstadter, co-founder of Canadian Optical Supply (COS) together with her late husband, Fred, passed away Saturday, September 7, 2024.

Learn More
MIDO Square

MIDO | Milano Eyewear Show Announces New Dates for 2026 Edition

The trade show will take place January 31 to February 2 to avoid overlapping the Milano Cortina 2026 Winter Olympic Games.

Read more
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked retinitis pigmentosa (XLRP).

Read more
CooperCompanies

CooperCompanies Recognized as a Best Workplace for Innovators

Leading global medical device company recognized for culture that drives innovation for customers and patients.

Read more
Nikon Optical Canada logo

Nikon Optical Unveils “Vision You Can Feel” Campaign in Canada

Nikon Optical Canada announces its launch of the 2024 brand campaign, Vision You Can Feel.

Read more